Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

There is a surprising number of products that come with into your home with stubborn stickers. A lot of stores still use price stickers, for instance, and glassware almost always has a sticker ...

3M (NYSE: MMM) recently reported its Q4’24 results, with revenues and earnings beating the street estimates. The company reported adjusted revenue of $5.81 billion and earnings of $1.68 on a per ...

The Immigration and Refugee Protection Act (IRPA) of 2002 provides the legislative authority for Canada’s immigration program. IRPA contains various provisions that allow the Minister to issue special ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

they are likely to miss some of the important instructions to be announced in the examination rooms/ halls. The NTA will not be responsible for any delay of the candidate to reach the examination ...

Shares of industrial conglomerate 3M (NYSE:MMM) jumped 6.1% in the pre-market session after the company reported fourth-quarter results, which exceeded analysts' revenue and EPS expectations.

(Reuters) -3M Co forecast profit growth for 2025 and beat fourth-quarter estimates as the U.S. industrial conglomerate benefited from efforts to revive sales and reduce costs, sending its shares ...

3M's end markets remain mixed, but management has a margin expansion opportunity. CEO Bill Brown will outline his vision for the company in February. The stock looks like a good value and is a ...